Analgesics in Kenya

Analgesics in Kenya


In analgesics, manufacturers are employing various strategies to tackle inflationary pressures in Kenya and maintain retail value share. Beta Healthcare International has introduced Hedex Extra, a stronger yet affordable painkiller specifically formulated for the Kenyan market. This player has also leveraged targeted marketing to compete with international brands like GSK Consumer Healthcare’s Panadol. Beta Healthcare’s marketing tactics include using simple, relatable messaging to target middle...

Euromonitor International's Analgesics in Kenya report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Analgesics in Kenya
Euromonitor International
October 2024
List Of Contents And Tables
ANALGESICS IN KENYA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Players compete for retail share with pricing and segmentation strategies
Kenya recalls children’s analgesic over safety concerns
Pharmacists influence brand success amid supply chain challenges
PROSPECTS AND OPPORTUNITIES
Inflation and supply chain issues threaten affordability and availability of analgesics
Paediatric pain relief to enjoy growth as adult combination analgesics decline
Rising demand for natural pain relief fuels growth in herbal remedies
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2019-2024
Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN KENYA
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings